GGrantIndex
Sort

35,931 grants matching parkinsons

Regulation of Motor Function in Parkinson's Disease

$638,182
Stella M Papa · Emory University · R01 · FY2020 · NS

Parkinson's Diseases Susceptibility Genes and Pesticides

$638,167
Beate R Ritz · University Of California Los Angeles · R01 · FY2012 · ES

Biomarkers for Preclinical Parkinson's disease

$638,073
Jing Zhang · University Of Washington · R01 · FY2009 · NS

Slow wave sleep as a biomarker of rehabilitation-induced cognitive improvement in Parkinson's disease

$638,047
Amy Willis Amara · University Of Alabama At Birmingham · R01 · FY2021 · HD

Vitamin K and D and Cognitive Impairment in Older Adults

$637,997
Sarah Booth · Tufts University Boston · R01 · FY2025 · AG

Cognitive intervention to improve simple and complex walking

$637,929
Joe Verghese · Albert Einstein College Of Medicine · R01 · FY2019 · AG

Wearable-Sensor System for Monitoring Motor Function

$637,832
Carlo J De Luca · Boston University (Charles River Campus) · R01 · FY2008 · EB

Identifying Factors Predicting ACcurately End-of-Life in Dementia with Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study

$637,754
Melissa Jo Armstrong · University Of Florida · R01 · FY2023 · AG

Prospective Memory in HIV-1 Infection

$637,698
Steven P Woods · University Of California, San Diego · R01 · FY2010 · MH

Determining the circuits and signals of sleep dysfunction in Parkinson's disease through chronic intracranial recordings and closed-loop Deep Brain Stimulation

$637,659
Simon Little · University Of California, San Francisco · R01 · FY2024 · NS

NOVEL PET MARKERS OF COGNITIVE IMPAIRMENT IN MANGANESE NEUROTOXICITY

$637,658
Susan Criswell · Washington University · R01 · FY2019 · ES

Links Between Production and Perception in Speech

$637,633
Carol A Fowler · Haskins Laboratories, Inc. · R01 · FY2007 · DC

Pathway targeted deep brain stimulation for Parkinson's disease

$637,548
Noam Harel · University Of Minnesota · R01 · FY2013 · NS

Protein aggregation in inclusion body and myofibrillar myopathies

$637,415
Conrad C Weihl · Washington University · R01 · FY2025 · AG

pH-Sensitive Glutamate Receptor Inhibitors: Clinical Candidate Selection

$637,385
Scott James Myers · Neurop, Inc. · R44 · FY2007 · NS

Higher Speed, Field and Spatial Resolution Brain 3D 1H MRS

$637,345
Oded Gonen · New York University School Of Medicine · R01 · FY2010 · EB

Neuromechanical modeling of postural responses: Cortical mechanisms of balance impairments in Parkinson's disease

$637,313
Lena H Ting · Emory University · R01 · FY2025 · HD

Striosomes Constrain Locomotor Vigor in Parkinson's disease and Other Movement Disorders

$637,265
Huaibin Cai · National Institute On Aging · ZIA · FY2024 · AG

PATHOLOG-OMICS - ESSENTIAL TREMOR IN THE BROADER CONTEXT OF NEURODEGENERATION

$637,117
Elan D Louis · Yale University · R01 · FY2015 · NS

Directing fate, subtype identity and survival in human pluripotent-derived midbrain dopamine neurons

$637,063
Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2022 · NS

Chronic Psychiatric Disorders: Linking Genes to Functional Disability

$637,054
Ann E Pulver · Johns Hopkins University · R01 · FY2011 · MH

Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons

$636,922
Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2023 · NS

Dual Mechanisms of Cognitive Control

$636,895
Todd Braver · Washington University · R37 · FY2022 · MH

GENETIC DISSECTION OF GLUTAMATE RECEPTOR FUNCTION

$636,629
Salk Institute For Biological Studies · R01 · FY2001 · NS

ENVIRONMENTAL EPIDEMIOLOGY OF ESSENTIAL TREMOR

$636,388
Columbia University Health Sciences · R01 · FY2002 · NS